Skip to content

Clinical impact of post-procedural fractional flow reserve on future restenosis in superficial femoral artery disease

Clinical impact of post-procedural fractional flow reserve on future restenosis in superficial femoral artery disease - post-procedural fractional flow reserve for superficial femoral aretery disease and restenosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000018614
Enrollment
60
Registered
2015-08-09
Start date
2013-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

superficial femoral artery disease

Interventions

None listed

Sponsors

Saiseikai Yokohama City Eastern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: successful endovascular therapy for superficial femoral artery disease

Exclusion criteria

Exclusion criteria: patients with aneurysm or stenosis at aorta or iliac artery, patients with congestive heart failure (New York Heart Association functional class 3-4), patients with severe pulmonary hypertension as evidenced by ultrasound cardiography, patients with no run-off vessel.

Design outcomes

Primary

MeasureTime frame
restenosis rate

Countries

Japan

Contacts

Public ContactNorihiro Kobayashi

Saiseikai Yokohama City Eastern Hospital Cardiology

ovation17@gmail.com+81-45-576-3000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026